Literature DB >> 9405285

Cross-talk between transcriptional regulation by thyroid hormone and myogenin: new aspects of the Ca2+-dependent expression of the fast-type sarcoplasmic reticulum Ca2+-ATPase.

M H Thelen1, W S Simonides, A Muller, C van Hardeveld.   

Abstract

We have previously demonstrated an interaction between the major determinants of skeletal muscle phenotype by showing that continuous contractile activity represses the thyroid hormone (3,3', 5-tri-iodothyronine; T3)-dependent transcriptional activity of fast-type sarcoplasmic/endoplasmic-reticulum Ca2+-ATPase (SERCA1), a characteristic of the fast phenotype. Both the free cytosolic Ca2+ concentration ([Ca2+]i) and the myogenic determination factors MyoD and myogenin have been implicated as mediators of the effect of contractile activity on skeletal muscle phenotype. Using L6 cells we have shown that an increase in the steady-state [Ca2+]i above the resting level of 120 nM indeed can mimic the effect of contractile activity on T3-dependent SERCA1 expression. We now show that the repressing effect of increased [Ca2+]i on T3-dependent SERCA1 expression in L6 cells is exerted at a pre-translational level and is accompanied by increased myogenin mRNA expression. Myogenin overexpression in these cells revealed that increased expression of myogenin alone strongly decreases the T3-dependent stimulation of SERCA1 promoter activity. These results suggest a pathway for the regulation of skeletal muscle phenotype in which [Ca2+]i mediates the effect of contractile activity by regulating the expression of myogenin, which in turn interferes with transcriptional regulation by T3.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9405285      PMCID: PMC1219023          DOI: 10.1042/bj3290131

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

Review 1.  Thyroid hormone regulation of gene expression.

Authors:  G A Brent; D D Moore; P R Larsen
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

2.  Differential regulation of MyoD and myogenin mRNA levels by nerve induced muscle activity.

Authors:  V Witzemann; B Sakmann
Journal:  FEBS Lett       Date:  1991-05-06       Impact factor: 4.124

3.  The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation.

Authors:  R L Davis; P F Cheng; A B Lassar; H Weintraub
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

4.  A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.

Authors:  D G Edmondson; E N Olson
Journal:  Genes Dev       Date:  1989-05       Impact factor: 11.361

Review 5.  The molecular basis of thyroid hormone action.

Authors:  L J DeGroot; A Nakai; A Sakurai; E Macchia
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

6.  Protein synthesis is required for the denervation-triggered activation of acetylcholine receptor genes.

Authors:  H J Tsay; C M Neville; J Schmidt
Journal:  FEBS Lett       Date:  1990-11-12       Impact factor: 4.124

7.  Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity.

Authors:  R Eftimie; H R Brenner; A Buonanno
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 8.  The myoD gene family: nodal point during specification of the muscle cell lineage.

Authors:  H Weintraub; R Davis; S Tapscott; M Thayer; M Krause; R Benezra; T K Blackwell; D Turner; R Rupp; S Hollenberg
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

9.  The elevation of sarcoplasmic reticulum Ca2(+)-ATPase levels by thyroid hormone in the L6 muscle cell line is potentiated by insulin-like growth factor-I.

Authors:  A Muller; C van Hardeveld; W S Simonides; J van Rijn
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

10.  Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products.

Authors:  T Braun; E Bober; G Buschhausen-Denker; S Kohtz; K H Grzeschik; H H Arnold; S Kotz
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  6 in total

Review 1.  Interaction between signalling pathways involved in skeletal muscle responses to endurance exercise.

Authors:  Nathalie Koulmann; André-Xavier Bigard
Journal:  Pflugers Arch       Date:  2006-01-18       Impact factor: 3.657

Review 2.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

3.  Myogenin induces higher oxidative capacity in pre-existing mouse muscle fibres after somatic DNA transfer.

Authors:  Merete Ekmark; Eirik Grønevik; Peter Schjerling; Kristian Gundersen
Journal:  J Physiol       Date:  2003-02-21       Impact factor: 5.182

4.  Alterations in slow-twitch muscle phenotype in transgenic mice overexpressing the Ca2+ buffering protein parvalbumin.

Authors:  Eva R Chin; Robert W Grange; Francois Viau; Alain R Simard; Caroline Humphries; John Shelton; Rhonda Bassel-Duby; R Sanders Williams; Robin N Michel
Journal:  J Physiol       Date:  2003-01-17       Impact factor: 5.182

5.  American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.

Authors:  Antonio C Bianco; Grant Anderson; Douglas Forrest; Valerie Anne Galton; Balázs Gereben; Brian W Kim; Peter A Kopp; Xiao Hui Liao; Maria Jesus Obregon; Robin P Peeters; Samuel Refetoff; David S Sharlin; Warner S Simonides; Roy E Weiss; Graham R Williams
Journal:  Thyroid       Date:  2013-12-12       Impact factor: 6.568

6.  A musculoskeletal model of low grade connective tissue inflammation in patients with thyroid associated ophthalmopathy (TAO): the WOMED concept of lateral tension and its general implications in disease.

Authors:  Roy Moncayo; Helga Moncayo
Journal:  BMC Musculoskelet Disord       Date:  2007-02-23       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.